A study exploring 25-year trends in mortality and burden of disease attributable to ambient air pollution from 1990 to 2015 found that ambient particle mass with a diameter <2.5 mm (PM 2.5 ) was the fifth-ranking global mortality risk factor in 2015. 3 Long-term exposure to PM 2.5 contributed to 4.2 million deaths in the same year, representing 7.6% of global deaths. Mortality from cardiovascular disease accounted for the most deaths attributable to ambient PM 2.5 air pollution: ambient PM 2.5 contributed to 17% of ischaemic heart disease, 14% of cerebrovascular disease, 16% of lung cancer and 27% of chronic obstructive pulmonary disease. Household air pollution from burning solid fuels was responsible for a further 2.8 million deaths. Although global mortality rates due to PM 2.5 exposure decreased during the observation period as a result of better air quality in high-income regions and decreasing mortality rates for cardiovascular diseases, there was an increase in attributable deaths due to an increase in air pollution in China and India, where the populations are both growing and ageing. Despite significant regional variations, ambient PM 2.5 ranked among the top 10 risk factors for mortality in each of the world's most populous countries. These data put ambient air pollution among the modifiable risk factors for cardiovascular diseases, as already recognized in 2010 by the American Heart Association 4 and subsequently by the European Society of Cardiology, 5, 6 and emphasize the need for specific and urgent action in this context.
How should clinicians face this new hazard in global health?
First, efforts must be made to understand the mechanisms linking air pollution to the onset of disease. In this issue, Vidale and Campana 7 analyse in depth the multiplicity of pathways through which air pollution negatively affects the cardiovascular system and therefore contribute to confirming its role in the pathogenesis of several aspects of cardiovascular disease, including vascular function, thrombosis and coagulation, and autonomic imbalance. Air pollution not only exerts a direct effect on the cardiovascular system, but can also act indirectly via the modulation of traditional risk factors for cardiovascular disease, such as insulin resistance, diabetes and metabolic syndrome, and the worsening or occurrence of arterial hypertension.
The second fundamental step is awareness: physicians should become aware of this invisible threat to global health and implement specific actions in their everyday clinical practice to minimize its effects. A recent paper proposed a detailed clinical approach in this regard, which can be summarized in four steps. 8 Initially, patients more susceptible to pollution-attributable cardiovascular diseases should be identified. This category includes patients with advanced age, lower socioeconomic status, obesity, diabetes, coronary artery disease, or other traditional cardiovascular risk factors. Subsequently, patients should be asked about the most frequent risk factors that predict exposure to fine particulate matter air pollution: the burning of solid fuels at home for different purposes, living or working in an urban or industrial environment, and Section of Cardiology, Department of Medicine, University of Verona, Italy the amount of time spent in heavy traffic. A quantitative risk assessment of the duration and concentration of PM 2.5 exposure should then be performed. This can be obtained through shared pollution models and risk calculators that facilitate the estimation of exposure to air pollution. Although we recognize the difficulties in implementing this strategy in daily clinical practice, it may be helpful for physicians to know that outdoor air pollution exposure maps already exist for some regions through the World Health Organization 9 and that several land-use regression and satellite measurements and chemical transport models have been developed that can be used for this purpose. Using specific models, exposure can then be translated into estimates of individual cardiovascular risk.
The last step consists in interventions and recommendations that should be offered to high-risk patients. In addition to general measures to undertake in conjunction with local governments, clinicians must be aware of their own key role because specific medical interventions can be achieved in individual patients. Education on indoor air filtration systems, information on air quality through automated air pollution alert networks (e.g. the Environmental Protection Agency's Airnow network, www.airnow.gov) and the use of personal filters can help to reduce exposure and minimize the risk to patients. Such interventions have been shown to improve blood pressure, ST segment depression, markers of inflammation and endothelial function. Educational interventions should also include advice on dietary supplements, such as olive oil, antioxidant vitamins and omega-3 polyunsaturated fatty acids, which have been shown to improve autonomic and endothelial dysfunction and oxidative stress reactions and may therefore protect against the detrimental effects of air pollutants.
There is currently no evidence from randomized controlled trials that improving outdoor and indoor air quality can have a positive effect on cardiovascular mortality. However, considering that 92% of the global population lives in places where the World Health Organization air pollution standards are not met, 9 active participation from all health professionals, governments and advocacy organizations cannot be deferred. Future research based on specific interventions targeted for selected populations will define the best strategies to reduce the impact of air pollution on global health. Acknowledgement I thank Prof. C. Ceconi for critical discussions of this paper.
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